Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement - Wikidata - wikimedia - TriplyDB

Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement

Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement

http://www.wikidata.org/entity/Q24613512

about

Decay accelerating activity of complement receptor type 1 (CD35). Two active sites are required for dissociating C5 convertases Membrane cofactor protein of the complement system: alternative splicing of serine/threonine/proline-rich exons and cytoplasmic tails produces multiple isoforms that correlate with protein phenotype Human meprin beta: O-linked glycans in the intervening region of the type I membrane protein protect the C-terminal region from proteolytic cleavage and diminish its secretion Structure of the axonal surface recognition molecule neurofascin and its relationship to a neural subgroup of the immunoglobulin superfamily The HeLa cell receptor for enterovirus 70 is decay-accelerating factor (CD55)Identification of an alternative polyadenylation site in the human C3b/C4b receptor (complement receptor type 1) transcriptional unit and prediction of a secreted form of complement receptor type 1 Structure of the human B lymphocyte receptor for C3d and the Epstein-Barr virus and relatedness to other members of the family of C3/C4 binding proteins Mapping CD55 function. The structure of two pathogen-binding domains at 1.7 A Interaction of Decay-Accelerating Factor with Coxsackievirus B3 The Crystal Structure of a Coxsackievirus B3-RD Variant and a Refined 9-Angstrom Cryo-Electron Microscopy Reconstruction of the Virus Complexed with Decay-Accelerating Factor (DAF) Provide a New Footprint of DAF on the Virus Surface Determinants for glycophospholipid anchoring of the Saccharomyces cerevisiae GAS1 protein to the plasma membrane.Structure/function studies of human decay-accelerating factor The good and evil of complement activation in HIV-1 infection C3b deposition on human erythrocytes induces the formation of a membrane skeleton-linked protein complex.Characterization of the decay-accelerating factor gene promoter region.Modeling how CD46 deficiency predisposes to atypical hemolytic uremic syndrome Glycolipid reanchoring of T-lymphocyte surface antigen CD8 using the 3' end sequence of decay-accelerating factor's mRNA A partial cDNA clone of trypomastigote decay-accelerating factor (T-DAF), a developmentally regulated complement inhibitor of Trypanosoma cruzi, has genetic and functional similarities to the human complement inhibitor DAF.Provirus activation plus CD59 blockage triggers antibody-dependent complement-mediated lysis of latently HIV-1-infected cells.Synthesis of aberrant decay-accelerating factor proteins by affected paroxysmal nocturnal hemoglobinuria leukocytes Dr(a-) polymorphism of decay accelerating factor. Biochemical, functional, and molecular characterization and production of allele-specific transfectants.In vitro attachment of glycosyl-inositolphospholipid anchor structures to mouse Thy-1 antigen and human decay-accelerating factor Sialic acid functions in enterovirus 70 binding and infection Insolubility and redistribution of GPI-anchored proteins at the cell surface after detergent treatment Complement and HIV-I infection/HIV-associated neurocognitive disorders.Targeted mouse complement inhibitor CR2-Crry protects against the development of atherosclerosis in mice.Targeting therapy to the neuromuscular junction: proof of concept.Specificity of coxsackievirus B3 interaction with human, but not murine, decay-accelerating factor: replacement of a single residue within short consensus repeat 2 prevents virus attachment Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses.Antigen-presenting cell engineering. The molecular toolbox Decay-accelerating factor protects human tumor cells from complement-mediated cytotoxicity in vitro.Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55).Characterization of the echovirus 7 receptor: domains of CD55 critical for virus binding The Salmonella typhimurium virulence plasmid complement resistance gene rck is homologous to a family of virulence-related outer membrane protein genes, including pagC and ail Phospholipid-anchored and transmembrane versions of either decay-accelerating factor or membrane cofactor protein show equal efficiency in protection from complement-mediated cell damage.Integrin-associated protein immunoglobulin domain is necessary for efficient vitronectin bead binding.The O-glycosylated stalk domain is required for apical sorting of neurotrophin receptors in polarized MDCK cells.The gene encoding decay-accelerating factor (DAF) is located in the complement-regulatory locus on the long arm of chromosome 1.Organization of the genes encoding complement receptors type 1 and 2, decay-accelerating factor, and C4-binding protein in the RCA locus on human chromosome 1.Molecular cloning and chromosomal localization of human membrane cofactor protein (MCP). Evidence for inclusion in the multigene family of complement-regulatory proteins

P2860

Q22010707-E888E90A-C066-414A-AA59-EFECA4EAB568 Q24318004-6551E446-3D09-491F-A96B-C55EB043053F Q24535259-B3B2145E-9525-4400-A09C-0019091FAED3 Q24643048-876A1742-E533-47C5-9391-3AE1EB4838C8 Q24682005-A6B13680-7FBA-4C92-9F23-702DE592909C Q24682397-7731FDB2-117D-41F2-B7FD-16BDB9B2D864 Q24682508-F3A2222C-84D7-43F9-BA8F-5DC0E8504892 Q27640215-BCF46DE6-DAC7-4035-8E16-94DA6491144B Q27647885-B9892038-17B0-472C-93FD-35DF8316AAA0 Q27673022-365D0CFF-9AAA-4157-A1D4-5CCA9828D259 Q27937642-51B824AC-6474-43A7-B7E7-D359B1D0870D Q28139971-21A709E6-75A6-4C5E-BE45-E0371643BDA7 Q28275986-4897628A-264A-4BDF-9D65-C9B89D5392FD Q30439939-AA472C8E-50FC-4C1F-83AE-F17264D17DA2 Q33263948-20200E1C-7161-4DDE-A7A9-9D63CB84B4B6 Q33372897-69939C27-936B-4823-997B-113AEBB9D970 Q33575118-CDD2D915-3A71-4036-89A2-BB11B9403BCF Q33607295-5FB04423-771C-4BDE-BBBA-7E123DBCD0FC Q34218827-D25FCB9B-71A0-4916-8DFA-4651B227C526 Q34239336-9024F74C-E6D1-425F-942D-0F1481FF040E Q34264494-9E931743-CFE5-4048-8732-94D3C93E125A Q34302627-A7B14949-DB8E-4A86-B816-9527CE914657 Q34355181-D065B4A4-AD2C-4C8F-AA32-6D691E27B195 Q34450170-D72AB09A-4436-4DC3-A395-98BE4D62D4B8 Q34610122-5AF05126-2BC6-467C-84F8-E16ECAED4634 Q34712205-14B91C2A-3123-431F-B5DA-3B642CF9DCC1 Q34974981-431FF892-284A-4994-8CD9-9D1EDE4D41A1 Q34991065-70ED1B21-7E20-4283-B34A-50718A9124A9 Q35563204-E369CB6C-04EF-46C6-82B3-E46647D39A49 Q35773889-35259B22-791A-4327-9CD4-AE453A90B4AA Q35811297-D8D1F32A-5ED5-4EF5-851B-33A2E58C0EDD Q35835449-A40B70D6-C685-47D0-8CF9-9140F3993B99 Q35845749-4A62C115-2F50-4CC2-A41A-40E76757A7F6 Q36109354-8E72FBDB-E392-47E5-BFE4-3BFD1F6FB8AA Q36230230-D1E6FF2B-4441-45C2-8A45-137BE8D60E43 Q36237374-821E2BEC-9490-4599-A6D6-301C4F498B11 Q36274330-C0C10990-730D-4DC8-B8E6-FAB73C7E183C Q36352748-6EF59777-D0D7-4C6F-AC90-D95CF954BD94 Q36354741-842C923F-A48F-4708-96C8-D38398CD6C84 Q36355033-2D6ADF13-DE04-44D3-B989-005FD8BD1D42

P2860

Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement

http://www.wikidata.org/entity/Q24613512

description

1987 nî lūn-bûn

@nan

1987 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

1987 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

1987年の論文

@ja

1987年学术文章

@wuu

1987年学术文章

@zh-cn

1987年学术文章

@zh-hans

1987年学术文章

@zh-my

1987年学术文章

@zh-sg

1987年學術文章

@yue

name

Cloning and characterization o ...... ing factor of human complement

@ast

Cloning and characterization o ...... ing factor of human complement

@en

Cloning and characterization o ...... ing factor of human complement

@nl

type

label

Cloning and characterization o ...... ing factor of human complement

@ast

Cloning and characterization o ...... ing factor of human complement

@en

Cloning and characterization o ...... ing factor of human complement

@nl

prefLabel

Cloning and characterization o ...... ing factor of human complement

@ast

Cloning and characterization o ...... ing factor of human complement

@en

Cloning and characterization o ...... ing factor of human complement

@nl

P1433

Q24613512-0720F078-B5D6-488B-BEB5-97E58FD4DD32

P1476

Q24613512-E45B1149-41C1-43B8-8218-27D3CD0872EF

P2093

Q24613512-2985FE1F-5319-4B7D-ADF3-975F2811B210

Q24613512-2C27966E-6AB5-47C2-900E-EA4202D8EB3F

Q24613512-2F1BE7FA-3111-4176-A934-AD2BB63C481D

Q24613512-340DAA8B-BF36-4036-90D0-2486239BC653

Q24613512-35397EDE-437D-4B1B-8EA8-15DE22EF7147

Q24613512-41901D76-91C0-4A88-B1CF-E1D21D7FFC07

Q24613512-54650419-298D-427C-B581-5D045F38901B

Q24613512-91C2500F-0862-4459-8106-913374393464

P2860

Q24613512-068C2A72-B6B4-48FD-9E02-BB0BFD028AF5

Q24613512-0A607D94-FEDF-44F1-B5FD-E1AF6B500D25

Q24613512-1D64B078-6311-4F29-8787-93C875B5AEE6

Q24613512-20CB86DB-68C3-45BE-8192-D9B001817ED3

Q24613512-27F27E31-0ACC-4C15-96E6-872D6CFAEB71

Q24613512-4B8F7D8F-7FC2-492F-913E-35B4E6D84666

Q24613512-4CC29894-26FE-46B4-8059-A7A075AED07E

Q24613512-568805F8-90A2-405F-A580-728CF57A49D6

Q24613512-64518CAB-9627-4FF9-A0C5-5EC42FF28171

Q24613512-696C6C28-EB3F-46B2-8FC2-A08608108152

P304

Q24613512-46C64851-C20D-4EEF-B2CC-DD0AC3623C0D

P31

Q24613512-8808E9D7-E1BB-4BDE-BF4B-B358CFC98AD2

P3181

Q24613512-169E39C0-830C-4559-8220-A1314CEE905B

P356

Q24613512-2960DD5D-B60F-4312-BF23-46D61427C564

P407

Q24613512-ED3B7E65-93B3-47A8-9BB4-CE13D1183E73

P433

Q24613512-3DE41A0A-BA67-4BB7-A4FC-537EFB1EC949

P478

Q24613512-C065479E-A977-4374-9657-C78FDAE23061

P577

Q24613512-04C4C3CB-3BFE-484A-9DE7-939F90FEF88B

P5875

Q24613512-DEB645FD-4381-4EF4-A112-914CD60E3395

P698

Q24613512-0655ADDF-C3A9-4D64-A715-439FE75D5A44

P932

Q24613512-15CAE7CC-7288-4E8D-8946-FDF579184A24

P3181

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Cloning and characterization o ...... ing factor of human complement

@en

P2093

D J Ayers

http://www.w3.org/2001/XMLSchema#string

D M Lublin

http://www.w3.org/2001/XMLSchema#string

J F Leykam

http://www.w3.org/2001/XMLSchema#string

J P Atkinson

http://www.w3.org/2001/XMLSchema#string

M E Medof

http://www.w3.org/2001/XMLSchema#string

M L Tykocinski

http://www.w3.org/2001/XMLSchema#string

R R Getty

http://www.w3.org/2001/XMLSchema#string

V M Holers

http://www.w3.org/2001/XMLSchema#string

P2860

DNA sequencing with chain-terminating inhibitors

Identification of a partial cDNA clone for the human receptor for complement fragments C3b/C4b

Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease

A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity

A simple and very efficient method for generating cDNA libraries

Sequencing end-labeled DNA with base-specific chemical cleavages

A molecular map of the human major histocompatibility complex class III region linking complement genes C4, C2 and factor B

Structural organization of the rat thy-1 gene

Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes

Molecular drive: a cohesive mode of species evolution

P304

2007-11

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4446756

http://www.w3.org/2001/XMLSchema#string

P356

10.1073/PNAS.84.7.2007

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

84

http://www.w3.org/2001/XMLSchema#string

P577

1987-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

20720332

http://www.w3.org/2001/XMLSchema#string

P698

2436222

http://www.w3.org/2001/XMLSchema#string

P932

304572

http://www.w3.org/2001/XMLSchema#string